Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use

A technology of protective immunity and antigenic epitopes, applied in the field of molecular immunology, can solve the problems of serious diseases and even death, loss of diagnostic significance of Mycobacterium tuberculosis infection, inability to escape immune recognition, etc., to promote the resolution and promotion of multi-drug resistance puzzle effect

Inactive Publication Date: 2006-11-08
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF1 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, multiple antibiotics need to be used in combination for at least 6 months, and due to the widespread emergence of Mtb drug-resistant strains, antibiotic treatment is often ineffective
The tuberculosis vaccine commonly used today, Bacillus Calmette-Guerin (BCG), has significant limitations: (1) Its effect on adult tuberculosis is not satisfactory; (2) It can cause severe disease and even death in immunocompromised individuals (3) It can cause positive skin test, making it lose its diagnostic significance in Mycobacterium tuberculosis infection
While vaccine research has focused on immunodominant epitopes, studies of minor determinants may focus the immune response on epitopes that cannot escape immune recognition
It has been reported that immunization of mice with a minor determinant of ESAT-6 can induce a significant protective immune response against TB, while some immunodominant epitopes cannot produce such a protective response

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use
  • Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use
  • Antigen epitope for exciting human anti-tubercle bacillus protective immunoreaction and its use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] 1Materials and methods

[0030] 1.1 Research object

[0031] There were 200 confirmed pulmonary tuberculosis patients, of which 100 were HLA-A*0201 positive and 100 were HLA-A*0201 negative, all of which were examined by radiology and clinical sputum culture. 100 HLA-A*0201 positive patients with other chronic lung diseases were the disease control group, and 100 HLA-A*0201 positive healthy volunteers were the normal control group.

[0032] 1.2 Reagents and kits:

[0033] Lymphocyte Separation Solution Lymphoprep TM Purchased from AXIS-SHIELD, Norway;

[0034] LPS, human recombinant IL-2, DMSO, BFA, β 2 -mg were purchased from Sigma;

[0035] Human recombinant GM-CSF and human recombinant IL-4 were purchased from R&D company;

[0036] RPMI1640 medium and fetal bovine serum were purchased from Gibco; (Sigma);

[0037] FITC-labeled anti-CD3, anti-CD8, anti-HLA.A2 flow cytometric monoclonal antibodies and FITC-labeled antibodies for detecting intracellular factors (IFN-γ, TNF-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to molecular immunology technology, and aims at screening out antigen epitope molecular simulation peptide capable of exciting human body's protective immunoreaction against tubercle bacillus, researching protective immunoreaction mechanism against tuberculosis, and further developing new type of concatenate polyepitope tuberculosis vaccine. The present invention provides one kind of antigen epitope molecular simulation peptide capable of exciting human body's protective immunoreaction against tubercle bacillus, and the peptide contains the amino acid sequence selected from SEQ ID Nos. 2, 5, 10, 12, 14 and 15. The present invention also provides the screening process and use of the peptide. The present invention may be used in preventing and controlling tuberculosis.

Description

Technical field: [0001] The present invention relates to the field of molecular immunology, in particular to molecular mimic peptides capable of stimulating the human body's protective immune response against tuberculosis bacilli and their screening methods and uses. Background technique: [0002] In recent years, tuberculosis (Tuberculosis, TB) has revived on a global scale. According to statistics from the World Health Organization, about one-third of the world's population and about 2 billion people are infected with Mycobacterium tuberculosis (Mtb), with about 9 million new cases each year, and up to 3 million deaths each year. The World Health Organization proposed a "global emergency" (global emergency). It can be seen that the impact and damage caused by tuberculosis to human health and the economy is difficult to simply assess. The characteristics of the epidemic of tuberculosis in my country are: high prevalence, high drug resistance rate, high death rate, high infection...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06A61K39/04A61P31/06
Inventor 邓安梅仲人前娄加陶吴传勇陈孙孝周晔陈燕陈波钱琤蒋廷旺
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap